Contributors |
|
viii | |
Preface |
|
xiii | |
Preface to the First Edition |
|
xiv | |
Acknowledgments |
|
xv | |
|
|
1 | (32) |
|
Historical Development of Cardiopulmonary Bypass in Minnesota |
|
|
3 | (18) |
|
|
The Birth of an Idea and the Development of Cardiopulmonary Bypass |
|
|
21 | (12) |
|
|
|
33 | (120) |
|
Blood Pumps in Cardiopulmonary Bypass |
|
|
35 | (12) |
|
|
|
Principles of Oxygenator Function: Gas Exchange, Heat Transfer, and Operation |
|
|
47 | (16) |
|
|
|
Circuitry and Cannulation Techniques |
|
|
63 | (51) |
|
|
Ultrafiltration and Dialysis |
|
|
114 | (14) |
|
|
|
Mechanical Circulatory Support Devices |
|
|
128 | (12) |
|
|
|
Cardiopulmonary Bypass for Minimally Invasive Cardiac Surgery |
|
|
140 | (13) |
|
|
|
Christina T. Mora Mangano |
|
|
SECTION III: PHYSIOLOGY AND PATHOLOGY |
|
|
153 | (256) |
|
Temperature Management in Cardiac Surgery |
|
|
155 | (17) |
|
|
|
172 | (18) |
|
|
Christopher B. Komanapalli |
|
|
|
Changes in the Pharmacokinetics and Pharmacodynamics of Drugs Administered During Cardiopulmonary Bypass |
|
|
190 | (71) |
|
|
|
|
261 | (21) |
|
|
|
Endocrine, Metabolic, and Electrolyte Responses |
|
|
282 | (29) |
|
|
|
Cardiopulmonary Bypass and the Lung |
|
|
311 | (10) |
|
|
|
Immune System and Inflammatory Responses to Cardiopulmonary Bypass |
|
|
321 | (17) |
|
|
|
|
Kidney Function and Cardiopulmonary Bypass |
|
|
338 | (14) |
|
|
Splanchnic Visceral, Metabolic, and Glucoregulatory Effects of Cardiopulmonary Bypass |
|
|
352 | (24) |
|
Veronica Christine Swanson |
|
|
|
Neurologic Effects of Cardiopulmonary Bypass |
|
|
376 | (33) |
|
|
|
409 | (132) |
|
Hemodilution and Priming Solutions |
|
|
411 | (12) |
|
|
|
The Blood-Surface Interface |
|
|
423 | (16) |
|
|
Hematologic Effects and Coagulopathy |
|
|
439 | (20) |
|
|
|
459 | (13) |
|
|
|
Anticoagulation for Cardiopulmonary Bypass |
|
|
472 | (30) |
|
|
|
|
502 | (20) |
|
|
|
Pharmacologic Prophylaxis for Post-Cardiopulmonary Bypass Bleeding |
|
|
522 | (19) |
|
|
|
SECTION V: CLINICAL APPLICATIONS |
|
|
541 | (142) |
|
Conduct of Cardiopulmonary Bypass |
|
|
543 | (29) |
|
|
|
|
Teamwork: A Systems-Based Practice |
|
|
572 | (17) |
|
|
|
Primum Non Nocere: Patient Safety in Cardiopulmonary Bypass |
|
|
589 | (19) |
|
|
Unusual Problems in Cardiopulmonary Bypass |
|
|
608 | (6) |
|
|
Termination of Cardiopulmonary Bypass |
|
|
614 | (18) |
|
|
|
|
ECMO for Respiratory Support in Adults |
|
|
632 | (15) |
|
|
|
|
Perfusion for Thoracic Aortic Surgery |
|
|
647 | (15) |
|
|
|
|
|
Noncardiac Surgical Applications of Cardiopulmonary Bypass |
|
|
662 | (21) |
|
|
|
|
SECTION VI: NEONATES, INFANTS, AND CHILDREN |
|
|
683 | (84) |
|
Pediatric Cardiopulmonary Bypass Overview: State of the Art and Future |
|
|
685 | (15) |
|
|
|
|
Myocardial Protection and Preservation for Neonates and Infants |
|
|
700 | (10) |
|
|
Brain Injury Following Infant Cardiac Surgery and Neuroprotective Strategies |
|
|
710 | (25) |
|
|
|
|
ECMO for Infants and Children |
|
|
735 | (21) |
|
|
|
|
Circulatory Assist Devices for Infants and Children |
|
|
756 | (11) |
|
|
Index |
|
767 | |